26 related articles for article (PubMed ID: 9511261)
1. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis.
Sirinek KR; Levine BA
Surg Gynecol Obstet; 1991; 172 Suppl():30-5. PubMed ID: 2024224
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic therapy of intra-abdominal sepsis in the elderly: experience with ticarcillin and clavulanic acid.
Fink MP
Surg Gynecol Obstet; 1991; 172 Suppl():36-41. PubMed ID: 2024225
[TBL] [Abstract][Full Text] [Related]
3. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
Dougherty SH; Sirinek KR; Schauer PR; Fink MP; Fabian TC; Martin DH; Wiedermann B
Am Surg; 1995 Apr; 61(4):297-303. PubMed ID: 7893090
[TBL] [Abstract][Full Text] [Related]
4. Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
Sanders CV; Pastorek JG; Miller JM; Aldridge KE
J Reprod Med; 1988 Jun; 33(6 Suppl):584-7. PubMed ID: 3260949
[TBL] [Abstract][Full Text] [Related]
5. The effect of timentin in the treatment of female pelvic soft tissue infections.
Faro S
Pharmacotherapy; 1991; 11(2 ( Pt 2)):80S-83S. PubMed ID: 2041836
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with Timentin].
Vacek V; Benes J; Kabelková M
Cas Lek Cesk; 1997 Dec; 136(24):764-7. PubMed ID: 9511261
[TBL] [Abstract][Full Text] [Related]
7. The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.
Ball P
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S113-7. PubMed ID: 17997283
[TBL] [Abstract][Full Text] [Related]
8. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
[TBL] [Abstract][Full Text] [Related]
9. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
10. Sulbactam-containing beta-lactamase inhibitor combinations.
Akova M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
[TBL] [Abstract][Full Text] [Related]
11. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
Giamarellou H
Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
